Bunnage Mark E. — SEC Form 4 filings

SEC reporting owner CIK 2100735. 5 Form 4 filings on record with FilingPulse; latest filed 2026-05-19.

Transaction summary — filings shown

Covers all 5 filings on record, filed 2026-02-12 to 2026-05-19. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
VERTEX PHARMACEUTICALS INC / MA (VRTX)EVP, Chief Scientific Officer55 legs · 6,293 sh · $2,999,7345

Form 4 filings — Bunnage Mark E.

FiledFormIssuerReported transactionsSource
2026-05-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Sale (S): 33 @ $453.45EDGAR
2026-02-264VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 582 @ $485.11 · Sale (S): 620 @ $486.35EDGAR
2026-02-194VERTEX PHARMACEUTICALS INC / MA (VRTX)Grant/award (A): 2,584 @ $0 · Tax withholding (F): 1,110 @ $483.75 · Sale (S): 2,437 @ $489.46 · Sale (S): 1,182 @ $473.68EDGAR
2026-02-184VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 2,283 @ $487.76EDGAR
2026-02-124VERTEX PHARMACEUTICALS INC / MA (VRTX)Tax withholding (F): 1,127 @ $468.41 · Sale (S): 2,021 @ $460.43EDGAR

FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=2100735 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →